| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC37A1 CNNM1 GJA3 GJA8 TRPV1 SLC7A13 SLC16A1 ABCB5 SLC35B3 SLC17A8 ATP11C SLC2A13 ANO10 ATP1A2 TMC5 SLC7A6 MFSD4B ITGAV SLC7A10 AQP9 ABCB1 SLC17A6 | 1.42e-12 | 1289 | 56 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC37A1 CNNM1 GJA3 GJA8 TRPV1 SLC7A13 SLC16A1 ABCB5 SLC35B3 SLC17A8 SLC2A13 ANO10 ATP1A2 TMC5 SLC7A6 MFSD4B ITGAV SLC7A10 AQP9 ABCB1 SLC17A6 | 2.47e-12 | 1180 | 56 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC37A1 SLC7A13 SLC16A1 ABCB5 SLC35B3 SLC17A8 SLC2A13 ATP1A2 SLC7A6 MFSD4B ABCB1 SLC17A6 | 6.48e-09 | 477 | 56 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC37A1 SLC7A13 SLC16A1 SLC35B3 SLC17A8 SLC7A6 SLC7A10 ABCB1 SLC17A6 | 1.16e-07 | 293 | 56 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC37A1 SLC7A13 SLC16A1 SLC35B3 SLC17A8 SLC2A13 SLC7A6 MFSD4B SLC17A6 | 1.26e-07 | 296 | 56 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.63e-06 | 71 | 56 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.75e-06 | 207 | 56 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.81e-06 | 208 | 56 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.13e-05 | 105 | 56 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | channel activity | 1.41e-05 | 525 | 56 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.44e-05 | 526 | 56 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 1.65e-05 | 18 | 56 | 3 | GO:0004708 | |
| GeneOntologyMolecularFunction | L-glutamate uniporter activity | 2.31e-05 | 3 | 56 | 2 | GO:0140788 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 4.06e-05 | 24 | 56 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.22e-05 | 138 | 56 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC37A1 TRPV1 SLC16A1 SLC17A8 SLC2A13 ANO10 ATP1A2 ITGAV AQP9 SLC17A6 | 4.28e-05 | 758 | 56 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 4.62e-05 | 4 | 56 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | symporter activity | 6.28e-05 | 150 | 56 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 7.68e-05 | 5 | 56 | 2 | GO:0022810 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 1.61e-04 | 7 | 56 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 3.10e-04 | 47 | 56 | 3 | GO:0004712 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPV1 SLC16A1 SLC17A8 SLC2A13 ANO10 ATP1A2 TMC5 ITGAV SLC17A6 | 3.33e-04 | 793 | 56 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | tRNA (cytidine) methyltransferase activity | 3.43e-04 | 10 | 56 | 2 | GO:0016427 | |
| GeneOntologyMolecularFunction | uniporter activity | 3.43e-04 | 10 | 56 | 2 | GO:0015292 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.47e-04 | 119 | 56 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.95e-04 | 51 | 56 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.97e-04 | 664 | 56 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 5.01e-04 | 12 | 56 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 5.91e-04 | 13 | 56 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | polyol transmembrane transporter activity | 5.91e-04 | 13 | 56 | 2 | GO:0015166 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 6.88e-04 | 14 | 56 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 7.92e-04 | 15 | 56 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 7.92e-04 | 15 | 56 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 9.04e-04 | 16 | 56 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | floppase activity | 9.04e-04 | 16 | 56 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.00e-03 | 70 | 56 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | flippase activity | 1.02e-03 | 17 | 56 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.18e-03 | 74 | 56 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.35e-03 | 171 | 56 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.42e-03 | 20 | 56 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.53e-03 | 301 | 56 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 1.57e-03 | 21 | 56 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.75e-03 | 459 | 56 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.78e-03 | 627 | 56 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.81e-03 | 86 | 56 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 2.22e-03 | 25 | 56 | 2 | GO:0005243 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.22e-03 | 25 | 56 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.79e-03 | 28 | 56 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.03e-03 | 103 | 56 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.55e-03 | 109 | 56 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | chemokine binding | 3.86e-03 | 33 | 56 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 4.09e-03 | 34 | 56 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | tRNA methyltransferase activity | 4.09e-03 | 34 | 56 | 2 | GO:0008175 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 4.83e-03 | 37 | 56 | 2 | GO:0022829 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.21e-03 | 125 | 56 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 5.36e-03 | 39 | 56 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 6.19e-03 | 42 | 56 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 7.39e-03 | 46 | 56 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 7.70e-03 | 144 | 56 | 3 | GO:0140101 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.85e-03 | 145 | 56 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 8.35e-03 | 49 | 56 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.77e-03 | 151 | 56 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 9.66e-03 | 465 | 56 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.19e-02 | 59 | 56 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.23e-02 | 171 | 56 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 1.25e-02 | 172 | 56 | 3 | GO:0008757 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC37A1 TRPV1 SLC7A13 SLC16A1 SLC35B3 SLC17A8 ATP1A2 SLC7A6 SLC7A10 AQP9 ABCB1 SLC17A6 | 8.54e-09 | 515 | 55 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.14e-08 | 163 | 55 | 8 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.38e-08 | 167 | 55 | 8 | GO:1903825 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | TRPV1 SLC7A13 SLC16A1 SLC17A8 ATP1A2 SLC7A6 SLC7A10 AQP9 ABCB1 SLC17A6 | 1.14e-07 | 410 | 55 | 10 | GO:0046942 |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.16e-07 | 87 | 55 | 6 | GO:1902475 | |
| GeneOntologyBiologicalProcess | organic acid transport | TRPV1 SLC7A13 SLC16A1 SLC17A8 ATP1A2 SLC7A6 SLC7A10 AQP9 ABCB1 SLC17A6 | 1.19e-07 | 412 | 55 | 10 | GO:0015849 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 4.22e-07 | 108 | 55 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 7.85e-07 | 120 | 55 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 7.85e-07 | 120 | 55 | 6 | GO:0006835 | |
| GeneOntologyBiologicalProcess | amino acid transport | 8.38e-07 | 195 | 55 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 2.23e-06 | 35 | 55 | 4 | GO:0015813 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 2.94e-06 | 84 | 55 | 5 | GO:0015800 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 6.79e-06 | 46 | 55 | 4 | GO:0051938 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CCR2 CNNM1 TRPV1 SLC16A1 SLC17A8 ATP11C NKAIN1 ANO10 ATP1A2 TMC5 MFSD4B ITGAV ABCB1 SLC17A6 | 1.04e-05 | 1374 | 55 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of Golgi inheritance | 4.17e-05 | 4 | 55 | 2 | GO:0090170 | |
| GeneOntologyBiologicalProcess | regulation of glutamate uptake involved in transmission of nerve impulse | 4.17e-05 | 4 | 55 | 2 | GO:0051946 | |
| GeneOntologyBiologicalProcess | regulation of amino acid uptake involved in synaptic transmission | 4.17e-05 | 4 | 55 | 2 | GO:0051941 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 7.65e-05 | 31 | 55 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 8.55e-05 | 87 | 55 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 8.93e-05 | 88 | 55 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | glutamate reuptake | 1.04e-04 | 6 | 55 | 2 | GO:0051935 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.17e-04 | 180 | 55 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | trachea formation | 1.45e-04 | 7 | 55 | 2 | GO:0060440 | |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 1.45e-04 | 7 | 55 | 2 | GO:1990349 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CCR2 TRPV1 SLC16A1 SLC17A8 ATP11C ANO10 ATP1A2 TMC5 ITGAV ABCB1 SLC17A6 | 1.46e-04 | 1115 | 55 | 11 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of L-glutamate import across plasma membrane | 3.10e-04 | 10 | 55 | 2 | GO:0002036 | |
| GeneOntologyBiologicalProcess | amino acid neurotransmitter reuptake | 3.10e-04 | 10 | 55 | 2 | GO:0051933 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 3.61e-04 | 52 | 55 | 3 | GO:0001504 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.78e-04 | 128 | 55 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | neurotransmitter loading into synaptic vesicle | 3.78e-04 | 11 | 55 | 2 | GO:0098700 | |
| GeneOntologyBiologicalProcess | intercellular transport | 3.78e-04 | 11 | 55 | 2 | GO:0010496 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 4.25e-04 | 132 | 55 | 4 | GO:0035249 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 4.49e-04 | 134 | 55 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in lung morphogenesis | 4.53e-04 | 12 | 55 | 2 | GO:0060502 | |
| GeneOntologyBiologicalProcess | trachea morphogenesis | 4.53e-04 | 12 | 55 | 2 | GO:0060439 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum membrane organization | 5.34e-04 | 13 | 55 | 2 | GO:0090158 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 5.34e-04 | 13 | 55 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | sodium-dependent phosphate transport | 5.34e-04 | 13 | 55 | 2 | GO:0044341 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 5.51e-04 | 60 | 55 | 3 | GO:0015804 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 6.22e-04 | 14 | 55 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | circulatory system process | 6.80e-04 | 733 | 55 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.40e-04 | 153 | 55 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.20e-04 | 275 | 55 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | stress-activated protein kinase signaling cascade | 8.30e-04 | 69 | 55 | 3 | GO:0031098 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 9.16e-04 | 162 | 55 | 4 | GO:0015748 | |
| GeneOntologyBiologicalProcess | regulation of Golgi organization | 1.04e-03 | 18 | 55 | 2 | GO:1903358 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 1.16e-03 | 19 | 55 | 2 | GO:0098712 | |
| GeneOntologyBiologicalProcess | establishment of blood-brain barrier | 1.16e-03 | 19 | 55 | 2 | GO:0060856 | |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 1.29e-03 | 20 | 55 | 2 | GO:2000641 | |
| GeneOntologyCellularComponent | pericellular basket | 2.11e-05 | 3 | 56 | 2 | GO:1990030 | |
| GeneOntologyCellularComponent | astrocyte end-foot | 4.57e-04 | 12 | 56 | 2 | GO:0097450 | |
| GeneOntologyCellularComponent | axon | GARS1 DOCK7 SLC17A8 ADGRL1 SLC2A13 MAP2K1 ADGRL3 ATL1 SLC17A6 | 5.57e-04 | 891 | 56 | 9 | GO:0030424 |
| Domain | MFS_dom | 2.65e-06 | 134 | 55 | 6 | IPR020846 | |
| Domain | MFS | 3.09e-06 | 77 | 55 | 5 | IPR011701 | |
| Domain | MFS_1 | 3.09e-06 | 77 | 55 | 5 | PF07690 | |
| Domain | AA/rel_permease1 | 6.77e-06 | 13 | 55 | 3 | IPR002293 | |
| Domain | AA_permease_2 | 6.77e-06 | 13 | 55 | 3 | PF13520 | |
| Domain | MFS | 1.63e-05 | 108 | 55 | 5 | PS50850 | |
| Domain | Latrophilin | 2.55e-05 | 3 | 55 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 2.55e-05 | 3 | 55 | 2 | IPR003334 | |
| Domain | AA-permease/SLC12A_dom | 3.58e-05 | 22 | 55 | 3 | IPR004841 | |
| Domain | AA_permease | 3.58e-05 | 22 | 55 | 3 | PF00324 | |
| Domain | MeTrfase | 5.09e-05 | 4 | 55 | 2 | IPR026113 | |
| Domain | Lectin_gal-bd_dom | 8.47e-05 | 5 | 55 | 2 | IPR000922 | |
| Domain | Gal_Lectin | 8.47e-05 | 5 | 55 | 2 | PF02140 | |
| Domain | SUEL_LECTIN | 8.47e-05 | 5 | 55 | 2 | PS50228 | |
| Domain | GPCR_2_latrophilin | 8.47e-05 | 5 | 55 | 2 | IPR003924 | |
| Domain | DUF3398 | 1.27e-04 | 6 | 55 | 2 | PF11878 | |
| Domain | Methyltransf_12 | 1.27e-04 | 6 | 55 | 2 | PF08242 | |
| Domain | DOCK_C/D_N | 1.27e-04 | 6 | 55 | 2 | IPR021816 | |
| Domain | Methyltransf_12 | 1.27e-04 | 6 | 55 | 2 | IPR013217 | |
| Domain | DOCK_C | 4.60e-04 | 11 | 55 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 4.60e-04 | 11 | 55 | 2 | IPR027007 | |
| Domain | DHR_2 | 4.60e-04 | 11 | 55 | 2 | PS51651 | |
| Domain | DHR_1 | 4.60e-04 | 11 | 55 | 2 | PS51650 | |
| Domain | DOCK-C2 | 4.60e-04 | 11 | 55 | 2 | PF14429 | |
| Domain | DHR-2 | 4.60e-04 | 11 | 55 | 2 | IPR027357 | |
| Domain | DHR-2 | 4.60e-04 | 11 | 55 | 2 | PF06920 | |
| Domain | GAIN_dom_N | 4.60e-04 | 11 | 55 | 2 | IPR032471 | |
| Domain | GAIN | 4.60e-04 | 11 | 55 | 2 | PF16489 | |
| Domain | DOCK | 4.60e-04 | 11 | 55 | 2 | IPR026791 | |
| Domain | Olfac-like_dom | 6.50e-04 | 13 | 55 | 2 | IPR003112 | |
| Domain | OLF | 6.50e-04 | 13 | 55 | 2 | SM00284 | |
| Domain | OLF | 6.50e-04 | 13 | 55 | 2 | PF02191 | |
| Domain | OLF | 6.50e-04 | 13 | 55 | 2 | PS51132 | |
| Domain | MORN | 8.72e-04 | 15 | 55 | 2 | PF02493 | |
| Domain | MORN | 8.72e-04 | 15 | 55 | 2 | IPR003409 | |
| Domain | CONNEXINS_1 | 1.41e-03 | 19 | 55 | 2 | PS00407 | |
| Domain | Connexin_N | 1.56e-03 | 20 | 55 | 2 | IPR013092 | |
| Domain | CONNEXINS_2 | 1.56e-03 | 20 | 55 | 2 | PS00408 | |
| Domain | Connexin | 1.56e-03 | 20 | 55 | 2 | PF00029 | |
| Domain | Connexin_CCC | 1.56e-03 | 20 | 55 | 2 | SM01089 | |
| Domain | Connexin_CS | 1.56e-03 | 20 | 55 | 2 | IPR017990 | |
| Domain | Connexin | 1.56e-03 | 20 | 55 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 1.56e-03 | 20 | 55 | 2 | IPR019570 | |
| Domain | CNX | 1.56e-03 | 20 | 55 | 2 | SM00037 | |
| Domain | ABC_membrane | 2.25e-03 | 24 | 55 | 2 | PF00664 | |
| Domain | HormR | 2.45e-03 | 25 | 55 | 2 | SM00008 | |
| Domain | ABC_TM1F | 3.06e-03 | 28 | 55 | 2 | PS50929 | |
| Domain | HRM | 3.06e-03 | 28 | 55 | 2 | PF02793 | |
| Domain | ABC1_TM_dom | 3.06e-03 | 28 | 55 | 2 | IPR011527 | |
| Domain | - | 3.99e-03 | 32 | 55 | 2 | 2.70.150.10 | |
| Domain | - | 3.99e-03 | 32 | 55 | 2 | 3.40.1110.10 | |
| Domain | GPS | 4.50e-03 | 34 | 55 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 4.50e-03 | 34 | 55 | 2 | IPR017983 | |
| Domain | GPS | 4.76e-03 | 35 | 55 | 2 | PF01825 | |
| Domain | ATPase_P-typ_cyto_domN | 4.76e-03 | 35 | 55 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.03e-03 | 36 | 55 | 2 | IPR018303 | |
| Domain | GPS | 5.03e-03 | 36 | 55 | 2 | PS50221 | |
| Domain | P_typ_ATPase | 5.03e-03 | 36 | 55 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.03e-03 | 36 | 55 | 2 | PS00154 | |
| Domain | GPS | 5.31e-03 | 37 | 55 | 2 | IPR000203 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.31e-03 | 37 | 55 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.31e-03 | 37 | 55 | 2 | PF00122 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 6.18e-03 | 40 | 55 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 6.18e-03 | 40 | 55 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 6.18e-03 | 40 | 55 | 2 | IPR001879 | |
| Domain | ABC_transporter_CS | 6.80e-03 | 42 | 55 | 2 | IPR017871 | |
| Domain | PSI | 8.11e-03 | 46 | 55 | 2 | SM00423 | |
| Domain | ABC_TRANSPORTER_2 | 8.81e-03 | 48 | 55 | 2 | PS50893 | |
| Domain | ABC_tran | 8.81e-03 | 48 | 55 | 2 | PF00005 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPV1 SLC16A1 ABCB5 SLC35B3 SLC17A8 ATP11C SLC2A13 ANO10 ATP1A2 SLC7A6 MFSD4B SLC7A10 AQP9 ABCB1 SLC17A6 | 2.82e-09 | 736 | 44 | 15 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPV1 SLC16A1 ABCB5 SLC35B3 SLC17A8 ATP11C SLC2A13 ANO10 ATP1A2 SLC7A6 SLC7A10 AQP9 ABCB1 SLC17A6 | 9.85e-09 | 681 | 44 | 14 | MM14985 |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 5.64e-07 | 6 | 44 | 3 | M47636 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC16A1 SLC35B3 SLC17A8 SLC2A13 SLC7A6 MFSD4B SLC7A10 SLC17A6 | 8.66e-07 | 249 | 44 | 8 | M5988 |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 4.60e-06 | 11 | 44 | 3 | M27420 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 8.06e-06 | 238 | 44 | 7 | MM15076 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.87e-05 | 17 | 44 | 3 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.87e-05 | 17 | 44 | 3 | MM1408 | |
| Pathway | PID_ANTHRAX_PATHWAY | 2.24e-05 | 18 | 44 | 3 | M267 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.65e-05 | 19 | 44 | 3 | MM15113 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 3.63e-05 | 21 | 44 | 3 | M878 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 3.63e-05 | 21 | 44 | 3 | M48342 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 5.49e-05 | 24 | 44 | 3 | MM17215 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 6.16e-05 | 69 | 44 | 4 | M237 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 6.22e-05 | 25 | 44 | 3 | M39574 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 6.22e-05 | 25 | 44 | 3 | M4974 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 7.02e-05 | 26 | 44 | 3 | M47565 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 7.02e-05 | 26 | 44 | 3 | MM1431 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 7.88e-05 | 27 | 44 | 3 | M7739 | |
| Pathway | WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION | 7.88e-05 | 27 | 44 | 3 | M39838 | |
| Pathway | WP_MAPK_CASCADE | 8.80e-05 | 28 | 44 | 3 | MM15976 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 9.46e-05 | 5 | 44 | 2 | M49016 | |
| Pathway | REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS | 9.80e-05 | 29 | 44 | 3 | M27431 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 1.42e-04 | 6 | 44 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 1.42e-04 | 6 | 44 | 2 | MM15273 | |
| Pathway | WP_MAPK_CASCADE | 1.45e-04 | 33 | 44 | 3 | M39594 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.59e-04 | 34 | 44 | 3 | M10287 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.59e-04 | 34 | 44 | 3 | M270 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.59e-04 | 34 | 44 | 3 | MM1399 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.89e-04 | 36 | 44 | 3 | M39908 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 2.05e-04 | 37 | 44 | 3 | M42558 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.81e-04 | 102 | 44 | 4 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.81e-04 | 102 | 44 | 4 | MM15830 | |
| Pathway | PID_CXCR3_PATHWAY | 3.21e-04 | 43 | 44 | 3 | M222 | |
| Pathway | WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1 | 3.38e-04 | 9 | 44 | 2 | M39481 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 3.44e-04 | 44 | 44 | 3 | M175 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.49e-04 | 108 | 44 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.62e-04 | 109 | 44 | 4 | MM15074 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 3.92e-04 | 46 | 44 | 3 | M39805 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 4.22e-04 | 10 | 44 | 2 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 4.22e-04 | 10 | 44 | 2 | M47420 | |
| Pathway | WP_ETHANOL_METABOLISM_RESULTING_IN_PRODUCTION_OF_ROS_BY_CYP2E1 | 4.22e-04 | 10 | 44 | 2 | MM15821 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 4.22e-04 | 10 | 44 | 2 | M47735 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 4.73e-04 | 49 | 44 | 3 | M39543 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.14e-04 | 11 | 44 | 2 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.14e-04 | 11 | 44 | 2 | M47371 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 5.32e-04 | 51 | 44 | 3 | M39457 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.16e-04 | 12 | 44 | 2 | M47369 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 6.16e-04 | 12 | 44 | 2 | M47597 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 6.16e-04 | 12 | 44 | 2 | M27350 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 6.16e-04 | 12 | 44 | 2 | MM15087 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 6.16e-04 | 12 | 44 | 2 | M47815 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 6.30e-04 | 54 | 44 | 3 | M42568 | |
| Pathway | WP_IL1_SIGNALING | 6.65e-04 | 55 | 44 | 3 | M39346 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 6.65e-04 | 55 | 44 | 3 | M39685 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 7.27e-04 | 13 | 44 | 2 | M47589 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 7.27e-04 | 13 | 44 | 2 | M89 | |
| Pathway | WP_OSTEOPONTIN_SIGNALING | 7.27e-04 | 13 | 44 | 2 | M39603 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M668 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47384 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 8.46e-04 | 14 | 44 | 2 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 8.46e-04 | 14 | 44 | 2 | MM14667 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 8.46e-04 | 14 | 44 | 2 | MM1457 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47488 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 8.46e-04 | 14 | 44 | 2 | MM1489 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47801 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 1.11e-03 | 16 | 44 | 2 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47682 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.23e-03 | 68 | 44 | 3 | MM14968 | |
| Pathway | WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE | 1.26e-03 | 17 | 44 | 2 | M39564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M47376 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M111 | |
| Pathway | WP_IL9_SIGNALING | 1.26e-03 | 17 | 44 | 2 | M39644 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 8226933 | ||
| Pubmed | Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. | 2.55e-06 | 2 | 56 | 2 | 9563949 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26017495 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 27956260 | ||
| Pubmed | Defining a link between gap junction communication, proteolysis, and cataract formation. | 2.55e-06 | 2 | 56 | 2 | 11395508 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17981815 | ||
| Pubmed | Latrophilin receptors: novel bronchodilator targets in asthma. | 2.55e-06 | 2 | 56 | 2 | 27325752 | |
| Pubmed | Knock-in of alpha3 connexin prevents severe cataracts caused by an alpha8 point mutation. | 2.55e-06 | 2 | 56 | 2 | 16687738 | |
| Pubmed | Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells. | 2.55e-06 | 2 | 56 | 2 | 28746311 | |
| Pubmed | Cataracts and microphthalmia caused by a Gja8 mutation in extracellular loop 2. | 2.55e-06 | 2 | 56 | 2 | 23300808 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12832465 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 34226295 | ||
| Pubmed | Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases. | 2.55e-06 | 2 | 56 | 2 | 30087384 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19014680 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22833572 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 30995319 | ||
| Pubmed | Cx46 hemichannels contribute to the sodium leak conductance in lens fiber cells. | 2.55e-06 | 2 | 56 | 2 | 24380846 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26163823 | ||
| Pubmed | Dominant cataracts result from incongruous mixing of wild-type lens connexins. | 2.55e-06 | 2 | 56 | 2 | 12782682 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 36189831 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22805292 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22805291 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26625317 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24804815 | ||
| Pubmed | Functional effects of Cx50 mutations associated with congenital cataracts. | 2.55e-06 | 2 | 56 | 2 | 24005045 | |
| Pubmed | Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway. | 2.55e-06 | 2 | 56 | 2 | 35975983 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16162927 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17507801 | ||
| Pubmed | Levels and Modifications of Both Lens Fiber Cell Connexins Are Affected in Connexin Mutant Mice. | 2.55e-06 | 2 | 56 | 2 | 36139360 | |
| Pubmed | Signaling Between TRPV1/TRPV4 and Intracellular Hydrostatic Pressure in the Mouse Lens. | 2.55e-06 | 2 | 56 | 2 | 32598448 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 36807640 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8529659 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21699731 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17419998 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1381507 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 33036381 | ||
| Pubmed | [Mek1 and Mek2 functions in the formation of the blood placental barrier]. | 2.55e-06 | 2 | 56 | 2 | 22549869 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23480967 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11875045 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23237773 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16696970 | ||
| Pubmed | MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response. | 2.55e-06 | 2 | 56 | 2 | 23735655 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26796213 | ||
| Pubmed | The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma. | 2.55e-06 | 2 | 56 | 2 | 35069558 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25103261 | ||
| Pubmed | Connexin 50 Regulates Surface Ball-and-Socket Structures and Fiber Cell Organization. | 2.55e-06 | 2 | 56 | 2 | 27281269 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26155939 | ||
| Pubmed | Connexin 50-R205G Mutation Perturbs Lens Epithelial Cell Proliferation and Differentiation. | 2.55e-06 | 2 | 56 | 2 | 32182330 | |
| Pubmed | Connections between connexins, calcium, and cataracts in the lens. | 2.55e-06 | 2 | 56 | 2 | 15452195 | |
| Pubmed | Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin. | 2.55e-06 | 2 | 56 | 2 | 19198628 | |
| Pubmed | Gap junction communication influences intercellular protein distribution in the lens. | 2.55e-06 | 2 | 56 | 2 | 18462719 | |
| Pubmed | Structure of native lens connexin 46/50 intercellular channels by cryo-EM. | 2.55e-06 | 2 | 56 | 2 | 30542154 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9860964 | ||
| Pubmed | Properties of connexin 46 hemichannels in dissociated lens fiber cells. | 2.55e-06 | 2 | 56 | 2 | 20861491 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21527500 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15979847 | ||
| Pubmed | ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro. | 2.55e-06 | 2 | 56 | 2 | 25491074 | |
| Pubmed | Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia. | 2.55e-06 | 2 | 56 | 2 | 19383924 | |
| Pubmed | Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. | 2.55e-06 | 2 | 56 | 2 | 20172001 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 10828601 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15284233 | ||
| Pubmed | Interaction between Connexin50 and mitogen-activated protein kinase signaling in lens homeostasis. | 2.55e-06 | 2 | 56 | 2 | 19321662 | |
| Pubmed | Unique and redundant connexin contributions to lens development. | 2.55e-06 | 2 | 56 | 2 | 11786642 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19156172 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12839928 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 31618082 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22561024 | ||
| Pubmed | Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells. | 2.55e-06 | 2 | 56 | 2 | 28559797 | |
| Pubmed | MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo. | 2.55e-06 | 2 | 56 | 2 | 16957420 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15543157 | ||
| Pubmed | Mutation analysis in Chinese families with autosomal dominant hereditary cataracts. | 2.55e-06 | 2 | 56 | 2 | 25549162 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16740340 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19144315 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19500021 | ||
| Pubmed | Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. | 2.55e-06 | 2 | 56 | 2 | 22197931 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 29938681 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18390968 | ||
| Pubmed | Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. | 7.63e-06 | 3 | 56 | 2 | 10489373 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 36880430 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 10994649 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25463315 | ||
| Pubmed | The multiple actions of black widow spider toxins and their selective use in neurosecretion studies. | 7.63e-06 | 3 | 56 | 2 | 15066411 | |
| Pubmed | Median raphe controls acquisition of negative experience in the mouse. | 7.63e-06 | 3 | 56 | 2 | 31780530 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25782435 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25600339 | ||
| Pubmed | Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy. | 7.63e-06 | 3 | 56 | 2 | 18060073 | |
| Pubmed | Lack of evidence for vesicular glutamate transporter expression in mouse astrocytes. | 7.63e-06 | 3 | 56 | 2 | 23467360 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 15557124 | ||
| Pubmed | Regulation of skeletal muscle insulin-stimulated signaling through the MEK-REDD1-mTOR axis. | 7.63e-06 | 3 | 56 | 2 | 27913296 | |
| Pubmed | Glutamate in primary afferents is required for itch transmission. | 7.63e-06 | 3 | 56 | 2 | 34986325 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 21458501 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22393900 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25615623 | ||
| Pubmed | Chromosomal localization of four MAPK signaling cascade genes: MEK1, MEK3, MEK4 and MEKK5. | 7.63e-06 | 3 | 56 | 2 | 9465908 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25585624 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 16611690 | ||
| Pubmed | p38mapk and MEK1/2 inhibition contribute to cellular oxidant injury after hypoxia. | 7.63e-06 | 3 | 56 | 2 | 14672918 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9542318 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25722381 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 10997882 | ||
| Interaction | TTYH1 interactions | 1.68e-06 | 300 | 56 | 8 | int:TTYH1 | |
| Interaction | NKAIN1 interactions | 3.19e-05 | 65 | 56 | 4 | int:NKAIN1 | |
| GeneFamily | Solute carriers | SLC37A1 SLC7A13 SLC16A1 SLC35B3 SLC17A8 SLC2A13 SLC7A6 SLC7A10 SLC17A6 | 3.73e-07 | 395 | 44 | 9 | 752 |
| GeneFamily | Mitogen-activated protein kinase kinases | 4.67e-07 | 7 | 44 | 3 | 653 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 3.46e-05 | 4 | 44 | 2 | 918 | |
| GeneFamily | ATP binding cassette subfamily B | 3.14e-04 | 11 | 44 | 2 | 806 | |
| GeneFamily | Gap junction proteins | 1.30e-03 | 22 | 44 | 2 | 314 | |
| GeneFamily | Methyltransferase like | 2.91e-03 | 33 | 44 | 2 | 963 | |
| Drug | AC1L3V8L | 2.80e-07 | 6 | 56 | 3 | CID000122778 | |
| Drug | Heptachlor | 3.12e-07 | 111 | 56 | 6 | ctd:D006533 | |
| Drug | HWY-289 | 7.82e-07 | 8 | 56 | 3 | CID000487138 | |
| Drug | mefloquina | 9.83e-07 | 31 | 56 | 4 | CID000004046 | |
| Drug | AC1L1F8K | 1.12e-06 | 32 | 56 | 4 | CID000003130 | |
| Drug | Zidovudine | SLC37A1 SLC16A1 SLC35B3 GARS1 SLC17A8 TRIM22 SLC7A10 AQP9 ABCB1 | 4.68e-06 | 521 | 56 | 9 | ctd:D015215 |
| Drug | TAK 733 | 5.94e-06 | 2 | 56 | 2 | ctd:C558666 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 5.94e-06 | 2 | 56 | 2 | CID005281903 | |
| Drug | mesochlorin e6 monoethylenediamine | 5.94e-06 | 2 | 56 | 2 | CID005488855 | |
| Drug | AC1L8LCS | 5.94e-06 | 2 | 56 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 5.94e-06 | 2 | 56 | 2 | CID000155836 | |
| Drug | DAPDOX | 5.94e-06 | 2 | 56 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 5.94e-06 | 2 | 56 | 2 | CID000164322 | |
| Drug | YM212 | 5.94e-06 | 2 | 56 | 2 | CID000129980 | |
| Drug | taxuspine C | 5.94e-06 | 2 | 56 | 2 | CID005321745 | |
| Drug | Ro11-2933 | 5.94e-06 | 2 | 56 | 2 | CID000115215 | |
| Drug | cnidiadin | 5.94e-06 | 2 | 56 | 2 | CID005315980 | |
| Drug | conferone | 5.94e-06 | 2 | 56 | 2 | CID001757335 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 5.94e-06 | 2 | 56 | 2 | CID000283230 | |
| Drug | VX-710-3 | 5.94e-06 | 2 | 56 | 2 | CID006450549 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 5.94e-06 | 2 | 56 | 2 | ctd:C544830 | |
| Drug | Ro44-5912 | 5.94e-06 | 2 | 56 | 2 | CID000197370 | |
| Drug | NAc-LLY-amide | 5.94e-06 | 2 | 56 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 5.94e-06 | 2 | 56 | 2 | CID006449905 | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; PC3; HT_HG-U133A | 8.56e-06 | 196 | 56 | 6 | 5723_DN | |
| Drug | FPT inhibitor II | 9.35e-06 | 17 | 56 | 3 | CID000001943 | |
| Drug | AC1L323L | 1.12e-05 | 18 | 56 | 3 | CID000133056 | |
| Drug | NIH-3 | 1.33e-05 | 19 | 56 | 3 | CID009822007 | |
| Drug | AC1MHEDP | 1.54e-05 | 61 | 56 | 4 | CID003002894 | |
| Drug | 1y2g | 1.64e-05 | 129 | 56 | 5 | CID005287936 | |
| Drug | 2-chloroquinazoline | 1.78e-05 | 3 | 56 | 2 | CID000074054 | |
| Drug | dendroamide A | 1.78e-05 | 3 | 56 | 2 | CID000177307 | |
| Drug | fluoroanilinoazatoxin | 1.78e-05 | 3 | 56 | 2 | CID000378896 | |
| Drug | RO5126766 | 1.78e-05 | 3 | 56 | 2 | ctd:C577924 | |
| Drug | Dihydrocyclosporin C | 1.78e-05 | 3 | 56 | 2 | CID000196411 | |
| Drug | NSC82591 | 1.78e-05 | 3 | 56 | 2 | CID000579054 | |
| Drug | CID5317124 | 1.78e-05 | 3 | 56 | 2 | CID005317124 | |
| Drug | NSC688503 | 1.78e-05 | 3 | 56 | 2 | CID000390744 | |
| Drug | Wp159 | 1.78e-05 | 3 | 56 | 2 | CID003060549 | |
| Drug | Cp-100356 | 1.78e-05 | 3 | 56 | 2 | CID000196918 | |
| Drug | BIBW22BS | 1.78e-05 | 3 | 56 | 2 | CID000132088 | |
| Drug | AC1L2Z11 | 1.78e-05 | 3 | 56 | 2 | CID000080228 | |
| Drug | AC1NSGRQ | 1.78e-05 | 3 | 56 | 2 | CID005333904 | |
| Drug | NK-250 | 1.78e-05 | 3 | 56 | 2 | CID000164220 | |
| Drug | 5-N-acetylardeemin | 1.78e-05 | 3 | 56 | 2 | CID000127303 | |
| Drug | 1-bromo-4-chlorobutane | 1.78e-05 | 3 | 56 | 2 | CID000081364 | |
| Drug | taxinine | 1.78e-05 | 3 | 56 | 2 | CID005321702 | |
| Drug | Hapalosin | 1.78e-05 | 3 | 56 | 2 | CID000133055 | |
| Drug | D-Val-Thz | 1.78e-05 | 3 | 56 | 2 | CID003082826 | |
| Drug | haemanthidine | 1.78e-05 | 3 | 56 | 2 | CID000124066 | |
| Drug | taccalonolide A | 1.78e-05 | 3 | 56 | 2 | CID000441685 | |
| Drug | taccalonolide E | 1.78e-05 | 3 | 56 | 2 | CID005321583 | |
| Drug | iodomycin | 1.78e-05 | 3 | 56 | 2 | CID000149155 | |
| Drug | R101933 | 1.78e-05 | 3 | 56 | 2 | CID000219080 | |
| Drug | AC1L87CG | 1.78e-05 | 3 | 56 | 2 | CID000373763 | |
| Drug | methylazatoxin | 1.78e-05 | 3 | 56 | 2 | CID000148162 | |
| Drug | TPGS | 1.82e-05 | 21 | 56 | 3 | CID000071406 | |
| Drug | Chebi:3796 | 1.82e-05 | 21 | 56 | 3 | CID006857420 | |
| Drug | Ns102 | 3.12e-05 | 25 | 56 | 3 | CID005311098 | |
| Drug | geldanamycin | 3.36e-05 | 371 | 56 | 7 | ctd:C001277 | |
| Drug | AC1L3NEP | 3.52e-05 | 26 | 56 | 3 | CID000092096 | |
| Drug | BIBX1382BS | 3.52e-05 | 26 | 56 | 3 | CID006918508 | |
| Drug | Gsh-pga1 | 3.55e-05 | 4 | 56 | 2 | CID005281911 | |
| Drug | 9-methylphenazine-1-carboxylic acid | 3.55e-05 | 4 | 56 | 2 | CID004037810 | |
| Drug | eupatin | 3.55e-05 | 4 | 56 | 2 | CID005317287 | |
| Drug | taxinine K | 3.55e-05 | 4 | 56 | 2 | CID005321708 | |
| Drug | AHC-52 | 3.55e-05 | 4 | 56 | 2 | CID000164115 | |
| Drug | NK-252 | 3.55e-05 | 4 | 56 | 2 | CID000130889 | |
| Drug | MS-073 | 3.55e-05 | 4 | 56 | 2 | CID000131119 | |
| Drug | AC1L9UH6 | 3.55e-05 | 4 | 56 | 2 | CID000456215 | |
| Drug | teludipine | 3.55e-05 | 4 | 56 | 2 | CID006436165 | |
| Drug | phellamurin | 3.55e-05 | 4 | 56 | 2 | CID000193876 | |
| Drug | S 9788 | 3.55e-05 | 4 | 56 | 2 | CID000107903 | |
| Drug | BBR 2378 | 3.55e-05 | 4 | 56 | 2 | CID000219053 | |
| Drug | erysolin | 3.55e-05 | 4 | 56 | 2 | CID003080557 | |
| Drug | Celecoxib | 3.66e-05 | 376 | 56 | 7 | ctd:D000068579 | |
| Drug | tariquidar | 3.95e-05 | 27 | 56 | 3 | CID000148201 | |
| Drug | anandamide | 4.42e-05 | 28 | 56 | 3 | ctd:C078814 | |
| Drug | tucaresol | 4.42e-05 | 28 | 56 | 3 | CID000055223 | |
| Drug | Csh Cyclosporin | 4.42e-05 | 28 | 56 | 3 | CID006436249 | |
| Drug | Texas Red | 4.42e-05 | 28 | 56 | 3 | CID000452705 | |
| Drug | 9-aminocamptothecin | 4.92e-05 | 29 | 56 | 3 | CID000072402 | |
| Drug | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 5.42e-05 | 400 | 56 | 7 | ctd:C085911 | |
| Drug | acetylvalerenolic acid | 5.91e-05 | 5 | 56 | 2 | CID006439585 | |
| Drug | thiodicarb | 5.91e-05 | 5 | 56 | 2 | CID000062155 | |
| Drug | Sdz 280 446 | 5.91e-05 | 5 | 56 | 2 | CID000164287 | |
| Drug | N-methylhomoveratrylamine | 5.91e-05 | 5 | 56 | 2 | CID000077039 | |
| Drug | AC1NSZ76 | 5.91e-05 | 5 | 56 | 2 | CID005320215 | |
| Drug | SDB-ethylenediamine | 5.91e-05 | 5 | 56 | 2 | CID006438957 | |
| Drug | Iaci | 5.91e-05 | 5 | 56 | 2 | CID000656579 | |
| Drug | N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime | 5.91e-05 | 5 | 56 | 2 | ctd:C068836 | |
| Drug | Cyclosporin C | 5.91e-05 | 5 | 56 | 2 | CID005287817 | |
| Drug | AC1L2MCS | 5.91e-05 | 5 | 56 | 2 | CID000023441 | |
| Drug | sarcolysin | 6.49e-05 | 172 | 56 | 5 | CID000004053 | |
| Drug | K00039 | 6.65e-05 | 32 | 56 | 3 | CID009549277 | |
| Drug | alfentanil | 6.65e-05 | 32 | 56 | 3 | CID000051263 | |
| Drug | AC1L1DBR | 7.30e-05 | 33 | 56 | 3 | CID000002279 | |
| Drug | AC1MJ1SO | 7.30e-05 | 33 | 56 | 3 | CID003084042 | |
| Drug | glyceryl 2-arachidonate | 8.72e-05 | 35 | 56 | 3 | ctd:C094503 | |
| Drug | tyrphostin A1 | 8.72e-05 | 35 | 56 | 3 | CID000002063 | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 1.06e-05 | 3 | 56 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | cataract (implicated_via_orthology) | 5.21e-05 | 38 | 56 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | RASopathy (implicated_via_orthology) | 1.26e-04 | 9 | 56 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | CATARACT, COPPOCK-LIKE | 1.26e-04 | 9 | 56 | 2 | C1852438 | |
| Disease | Cataract, Pulverulent | 1.26e-04 | 9 | 56 | 2 | C1833118 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.26e-04 | 9 | 56 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Turner Syndrome, Male | 1.92e-04 | 11 | 56 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.92e-04 | 11 | 56 | 2 | C1527404 | |
| Disease | Noonan Syndrome 1 | 1.92e-04 | 11 | 56 | 2 | C4551602 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 2.72e-04 | 13 | 56 | 2 | OBA_2045159 | |
| Disease | Nuclear cataract | 5.31e-04 | 18 | 56 | 2 | C0392557 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 5.31e-04 | 18 | 56 | 2 | OBA_2045155 | |
| Disease | Nuclear non-senile cataract | 5.31e-04 | 18 | 56 | 2 | C1112705 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 5.93e-04 | 19 | 56 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 5.93e-04 | 19 | 56 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 5.93e-04 | 19 | 56 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 5.93e-04 | 19 | 56 | 2 | C1275081 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 7.26e-04 | 21 | 56 | 2 | OBA_2045156 | |
| Disease | LEOPARD Syndrome | 7.98e-04 | 22 | 56 | 2 | C0175704 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 8.72e-04 | 23 | 56 | 2 | OBA_2045158 | |
| Disease | Noonan Syndrome | 9.51e-04 | 24 | 56 | 2 | C0028326 | |
| Disease | melanoma | 1.27e-03 | 248 | 56 | 4 | C0025202 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.30e-03 | 28 | 56 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in very large HDL percentage | 1.59e-03 | 31 | 56 | 2 | EFO_0022243 | |
| Disease | pursuit maintenance gain measurement | 1.67e-03 | 123 | 56 | 3 | EFO_0008433 | |
| Disease | Malignant Neoplasms | 1.87e-03 | 128 | 56 | 3 | C0006826 | |
| Disease | esterified cholesterol measurement | 1.87e-03 | 128 | 56 | 3 | EFO_0008589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGAFVGAATVFGIYY | 111 | O43315 | |
| DYAYVTEIFGGLAGF | 106 | Q9NS82 | |
| FNIGGRGFKAYYFSG | 241 | Q5VXM1 | |
| HAFIYFAYAAGFRFG | 926 | Q2M3G0 | |
| FAYAAGFRFGAYLIQ | 931 | Q2M3G0 | |
| VDGTGFVVYDGAVFY | 211 | O94910 | |
| VDGTGFVVYDGALFF | 206 | Q9HAR2 | |
| GVGIFSFARYGSDFY | 196 | Q86W34 | |
| TNGDYVFFYLDVFGE | 246 | P20594 | |
| FLFEGYFGTILYTGD | 106 | Q9H816 | |
| IVGFYGAFYSDGEIS | 126 | Q02750 | |
| VGFYGAFYSDGEISI | 131 | P36507 | |
| LYLNGDFDGGNFYFT | 616 | Q32P28 | |
| FSYAGCFRFGAYLVA | 951 | P08183 | |
| RGYFGETIALYFGFL | 201 | Q9NW15 | |
| TTYVGFCVYAGFFGF | 351 | P53985 | |
| YEEFGAFGGYGTLTS | 36 | Q96JG8 | |
| EFMFSYGNFGYGFSH | 236 | Q53TS8 | |
| VSHFDIFYIYGFASG | 236 | O75051 | |
| IFYIYGFASGGFVYF | 241 | O75051 | |
| FETGSYFFYLDGENV | 6 | P23409 | |
| GNFYVRGDGTRVYFF | 311 | Q6P1Q9 | |
| EVAGFSYFYGAFLVG | 186 | Q6P1A2 | |
| GFDGIYTYFATNGFT | 316 | Q5SRI9 | |
| LFFFFYVGAEVTYGS | 236 | Q5TF39 | |
| GNFYVRGDGTRVYFF | 311 | Q96IZ6 | |
| ASGAFTALFGLGYFY | 136 | P57057 | |
| GGFFTYFVILAENGF | 861 | P50993 | |
| FPYEFSYGADGGAKF | 221 | Q8WXF7 | |
| RVFGTYFRVGFYGAH | 1746 | Q96HP0 | |
| YFRVGFYGAHFGDLD | 1751 | Q96HP0 | |
| TYFRVGFYGTKFGDL | 1841 | Q96N67 | |
| VADSEGDFYYGGAVF | 251 | Q8N5D6 | |
| FEVGFIVGHYFLYGF | 161 | P48165 | |
| YSGPEGSYFGFAVDF | 41 | P06756 | |
| EAVGTAVDYGYFRFF | 776 | Q9P2S6 | |
| FTGLYHIGYFGGIFF | 116 | P41597 | |
| VGFIAGQYFLYGFEL | 161 | Q9Y6H8 | |
| FHGVFYAGGFAIVYY | 21 | Q9GZY4 | |
| FYTVTFYGALFREGD | 121 | P46734 | |
| TYYGAFFLYAGFAAV | 571 | Q96QE2 | |
| FVDFAVYSGGVYLFT | 106 | Q9NX61 | |
| RFFYDQAFAIYGGVS | 131 | P41250 | |
| QAFAIYGGVSGLYDF | 136 | P41250 | |
| FFFFDGSTLEGYYVD | 51 | Q8WTS6 | |
| TYGYAFLFSLTGYFG | 296 | Q9H1N7 | |
| IKFFTGDVFGYHGYT | 151 | Q9UBE0 | |
| DSFDFIGGFDSYGYQ | 176 | Q4KMZ8 | |
| ESAGGFYYVESGKLF | 81 | Q12769 | |
| EGLRFENGAFTYYGV | 686 | Q9NRU3 | |
| AAFEGTVFFFGTYFL | 966 | Q8NB49 | |
| VHYGGVIFYAIFASG | 486 | Q9P2U8 | |
| SVLGGVYFFFRGIQY | 481 | Q8NER1 | |
| FGYAALVTFGSIFGY | 6 | Q9Y6G1 | |
| IFQGYFAYSGGACFT | 211 | Q8TCU3 | |
| SYAYILEAFGGFIAF | 111 | Q92536 | |
| AQTGFYGEFIIGEDY | 241 | Q96IT1 | |
| FTGLEFFTGVGYFRD | 486 | Q6UXY8 | |
| AFGVFGCQYFSSGKY | 341 | Q8IYM9 | |
| HYSGVIFYGVFASGE | 491 | Q8NDX2 |